Coartem Tablet
Product Images NDC 0078-0568

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Coartem (NDC 0078-0568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Artemether Structural Formula (Coartem 01)

Chemical structure of artemether, one of the active ingredients in COARTEM tablets (artemether and lumefantrine). The diagram shows the molecular arrangement including oxygen and methyl groups.*

FDA Label Image

Lumefantrine Structural Formula (Coartem 02)

Chemical structure diagram of artemether, one of the active ingredients in COARTEM (artemether and lumefantrine) tablets by Novartis Pharmaceuticals Corporation.*

FDA Label Image

Principal Display Panel – Package Label – 20 mg/120 mg Tablets (Coartem 03)

Coartem tablets containing artemether 20 mg and lumefantrine 120 mg per tablet are displayed on a label from Novartis Pharmaceuticals Corporation. The package contains 24 tablets intended for oral use. The label includes the NDC 0078-0568-45 and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.